In contrast, the 4T1 tumor–bearing mice showed complete progression upon anti–PD-1 plus anti–CTLA-4 treatment (Figure 4C), which we considered to represent a model of true tumor progression. This evidence concerns the gene CTLA4 and neoplasm.